Spots Global Cancer Trial Database for Stage III NSCLC RWE in Chinese Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Stage III NSCLC RWE in Chinese Patients
Official Title: Real-World Molecular Testing, Treatment Patterns and Clinical Outcomes in Chinese Patients With Stage III NSCLC- A Prospective, Non-Interventional Study(MOOREA)
Study ID: NCT04023812
Conditions
Interventions
Study Description
Brief Summary: The objectives of this study are to assess molecular testing, treatment patterns and associated clinical outcomes in Chinese patients with treatment-naïve stage III non-small cell lung cancer (NSCLC) in real world setting. This study is a prospective, non-interventional study. It is descriptive in nature and does not attempt to test any specific a priori hypotheses.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Bei Jing, , China
Research Site, Bei Jing, , China
Research Site, Bei Jing, , China
Research Site, Chang Chun, , China
Research Site, Chengdu, , China
Research Site, Chengdu, , China
Research Site, Da Tong, , China
Research Site, Da Tong, , China
Research Site, Fen Yang, , China
Research Site, Guang Zhou, , China
Research Site, He Fei, , China
Research Site, Hong Kong, , China
Research Site, Ji Nan, , China
Research Site, Nan Ning, , China
Research Site, Qing Dao, , China
Research Site, Shan Tou, , China
Research Site, Shanghai, , China
Research Site, Shanghai, , China
Research Site, Shanghai, , China
Research Site, Shijiazhuang, , China
Research Site, Shijiazhuang, , China
Research Site, Shijiazhuang, , China
Research Site, Tai Zhou, , China
Research Site, Tian Jin, , China
Research Site, Yin Chuan, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
